| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Oct 29, 2020 | Sale | $26.15 | 33,119 | 865,949 | 543,803 | Oct 30, 2020, 08:24 PM | |
| RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO & President | Oct 13, 2020 | Option Exercise | $27.62 | 66,106 | 1,825,848 | 769,564 | Oct 15, 2020, 06:57 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Sep 30, 2020 | Option Exercise | $25.14 | 6,051 | 152,122 | 45,513 | Oct 02, 2020, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO & President | Sep 30, 2020 | Option Exercise | $25.14 | 143,269 | 3,601,783 | 571,231 | Oct 02, 2020, 08:33 PM | |
| RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | Sep 30, 2020 | Option Exercise | $25.14 | 5,446 | 136,912 | 49,862 | Oct 02, 2020, 08:32 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Sep 30, 2020 | Option Exercise | $25.14 | 7,382 | 185,583 | 111,950 | Oct 02, 2020, 08:31 PM | |
| RVNC | Revance Therapeutics, Inc. | Moxie Dwight | SVP, GC & Secretary | Sep 30, 2020 | Option Exercise | $25.14 | 4,236 | 106,493 | 33,014 | Oct 02, 2020, 08:30 PM | |
| RVNC | Revance Therapeutics, Inc. | Rankin Aubrey | President, Innovation & Tech | Sep 28, 2020 | Sale | $26.18 | 33,119 | 867,055 | 576,922 | Sep 30, 2020, 09:21 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Jun 30, 2020 | Option Exercise | $13.80 | 1,000 | 13,795 | 34,064 | Jul 02, 2020, 08:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | Jun 30, 2020 | Option Exercise | $13.80 | 763 | 10,526 | 39,558 | Jul 02, 2020, 08:18 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Apr 15, 2020 | Option Exercise | $14.80 | 432 | 6,394 | 33,064 | Apr 17, 2020, 07:51 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President of R&D | Mar 15, 2020 | Option Exercise | $15.50 | 1,354 | 20,987 | 101,832 | Mar 17, 2020, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | McDowell Caryn Gordon | SVP, GC & Secretary | Feb 15, 2020 | Option Exercise | $25.33 | 864 | 21,885 | 23,453 | Feb 19, 2020, 08:23 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | COO, President, R&D | Feb 15, 2020 | Option Exercise | $25.33 | 3,325 | 84,222 | 103,186 | Feb 19, 2020, 08:22 PM | |
| RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | Feb 15, 2020 | Option Exercise | $25.33 | 576 | 14,590 | 38,795 | Feb 19, 2020, 08:21 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Feb 15, 2020 | Option Exercise | $25.33 | 288 | 7,295 | 33,496 | Feb 19, 2020, 08:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Jan 15, 2020 | Option Exercise | $22.89 | 4,441 | 101,654 | 81,511 | Jan 17, 2020, 08:12 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Dec 31, 2019 | Option Exercise | $10.82 | 382 | 4,133 | 13,784 | Jan 03, 2020, 06:48 PM | |
| RVNC | Revance Therapeutics, Inc. | McDowell Caryn Gordon | SVP, GC & Secretary | Dec 31, 2019 | Option Exercise | $10.82 | 382 | 4,133 | 24,317 | Jan 03, 2020, 06:46 PM | |
| RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | Dec 31, 2019 | Option Exercise | $10.82 | 504 | 5,453 | 22,871 | Jan 03, 2020, 06:42 PM | |
| RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | Chief Commercial Officer | Dec 15, 2019 | Option Exercise | $15.99 | 576 | 9,210 | 11,492 | Dec 17, 2019, 08:00 PM | |
| RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | Dec 15, 2019 | Option Exercise | $15.99 | 1,556 | 24,880 | 22,367 | Dec 17, 2019, 07:57 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2019 | Option Exercise | $15.99 | 2,971 | 47,506 | 85,952 | Dec 17, 2019, 07:56 PM | |
| RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | Jun 28, 2019 | Option Exercise | $11.02 | 923 | 10,176 | 23,923 | Jul 02, 2019, 09:16 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 28, 2019 | Option Exercise | $11.02 | 1,000 | 11,024 | 152,193 | Jul 02, 2019, 09:15 PM | |
| RVNC | Revance Therapeutics, Inc. | McDowell Caryn Gordon | SVP, GC & Secretary | Jun 28, 2019 | Option Exercise | $11.02 | 1,000 | 11,024 | 23,935 | Jul 02, 2019, 09:14 PM | |
| RVNC | Revance Therapeutics, Inc. | McDowell Caryn Gordon | SVP, GC & Secretary | Jun 15, 2019 | Option Exercise | $10.86 | 1,383 | 15,019 | 22,935 | Jun 17, 2019, 08:30 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 18, 2019 | Sale | $15.51 | 11,613 | 180,068 | 151,193 | Mar 19, 2019, 09:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 15, 2019 | Option Exercise | $15.45 | 6,137 | 94,817 | 165,687 | Mar 19, 2019, 09:01 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Mar 15, 2019 | Option Exercise | $15.45 | 252 | 3,893 | 6,898 | Mar 19, 2019, 08:58 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Mar 18, 2019 | Sale | $15.48 | 498 | 7,709 | 6,400 | Mar 19, 2019, 08:58 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 14, 2019 | Option Exercise | $4.20 | 666 | 2,797 | 90,443 | Mar 18, 2019, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 15, 2019 | Option Exercise | $15.45 | 1,354 | 20,919 | 88,923 | Mar 18, 2019, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 14, 2019 | Option Exercise | $15.59 | 166 | 2,588 | 90,277 | Mar 18, 2019, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Feb 15, 2019 | Option Exercise | $17.69 | 1,510 | 26,712 | 89,777 | Feb 20, 2019, 09:33 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 15, 2019 | Option Exercise | $17.69 | 3,154 | 55,794 | 174,389 | Feb 20, 2019, 09:31 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 19, 2019 | Sale | $17.68 | 5,446 | 96,285 | 168,943 | Feb 20, 2019, 09:31 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Jan 22, 2019 | Sale | $17.77 | 625 | 11,106 | 4,000 | Jan 23, 2019, 09:38 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Jan 22, 2019 | Option Exercise | $13.35 | 625 | 8,344 | 4,625 | Jan 23, 2019, 09:38 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Jan 15, 2019 | Option Exercise | $20.19 | 4,466 | 90,169 | 75,537 | Jan 17, 2019, 08:55 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Jan 03, 2019 | Sale | $19.48 | 375 | 7,305 | 4,000 | Jan 04, 2019, 09:33 PM | |
| RVNC | Revance Therapeutics, Inc. | McDowell Caryn Gordon | SVP, GC & Secretary | Dec 31, 2018 | Option Exercise | $17.11 | 818 | 13,996 | 16,818 | Jan 02, 2019, 08:05 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Dec 31, 2018 | Option Exercise | $17.11 | 375 | 6,416 | 4,375 | Jan 02, 2019, 08:02 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2018 | Option Exercise | $19.91 | 4,260 | 84,817 | 80,003 | Dec 14, 2018, 09:23 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 20, 2018 | Sale | $20.66 | 491 | 10,144 | 4,000 | Nov 21, 2018, 06:30 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 15, 2018 | Option Exercise | $20.99 | 259 | 5,436 | 4,491 | Nov 16, 2018, 06:17 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 09, 2018 | Option Exercise | $13.35 | 2,188 | 29,210 | 6,938 | Nov 09, 2018, 08:59 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Accounting Officer | Nov 09, 2018 | Sale | $23.72 | 2,188 | 51,899 | 4,750 | Nov 09, 2018, 08:59 PM | |
| RVNC | Revance Therapeutics, Inc. | Zavodnick Todd Erik | CCO & President, | Oct 15, 2018 | Option Exercise | $23.94 | 7,093 | 169,806 | 96,407 | Oct 17, 2018, 06:53 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Financial Officer | Jul 06, 2018 | Sale | $28.35 | 393 | 11,142 | 4,750 | Jul 06, 2018, 09:17 PM | |
| RVNC | Revance Therapeutics, Inc. | Allouche Cyril | Principal Financial Officer | Jun 29, 2018 | Option Exercise | $23.33 | 393 | 9,170 | 5,143 | Jul 03, 2018, 08:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 29, 2018 | Option Exercise | $23.33 | 668 | 15,586 | 142,543 | Jul 03, 2018, 08:17 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO & CBO | May 22, 2018 | Sale | $30.25 | 2,874 | 86,924 | 65,497 | May 24, 2018, 07:24 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Mar 21, 2018 | Option Exercise | $2.55 | 666 | 1,698 | 84,263 | Mar 23, 2018, 09:13 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 22, 2018 | Sale | $30.85 | 3,431 | 105,839 | 68,371 | Mar 23, 2018, 09:12 PM | |
| RVNC | Revance Therapeutics, Inc. | GARDNER PHYLLIS | Director | Mar 16, 2018 | Option Exercise | $2.55 | 5,333 | 13,599 | 8,333 | Mar 16, 2018, 08:35 PM | |
| RVNC | Revance Therapeutics, Inc. | GARDNER PHYLLIS | Director | Mar 16, 2018 | Sale | $31.51 | 5,333 | 168,045 | 3,000 | Mar 16, 2018, 08:35 PM | |
| RVNC | Revance Therapeutics, Inc. | Vickers Philip J. | Director | Mar 16, 2018 | Buy | $31.24 | 3,150 | 98,393 | 6,150 | Mar 16, 2018, 08:05 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 16, 2018 | Sale | $31.43 | 5,452 | 171,348 | 141,875 | Mar 16, 2018, 08:03 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 15, 2018 | Option Exercise | $31.65 | 2,881 | 91,184 | 127,327 | Mar 16, 2018, 08:03 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 15, 2018 | Sale | $32.80 | 1,000 | 32,800 | 130,208 | Mar 16, 2018, 08:03 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 16, 2018 | Option Exercise | $2.55 | 20,000 | 51,000 | 147,327 | Mar 16, 2018, 08:03 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 13, 2018 | Sale | $34.50 | 25,867 | 892,412 | 72,954 | Mar 15, 2018, 08:54 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 15, 2018 | Option Exercise | $31.65 | 1,152 | 36,461 | 71,802 | Mar 15, 2018, 08:54 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 13, 2018 | Option Exercise | $8.70 | 25,867 | 225,043 | 98,821 | Mar 15, 2018, 08:54 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 07, 2018 | Sale | $31.43 | 27,283 | 857,505 | 131,208 | Mar 09, 2018, 08:36 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 07, 2018 | Option Exercise | $8.70 | 10,000 | 87,000 | 82,954 | Mar 09, 2018, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 07, 2018 | Sale | $31.50 | 10,000 | 315,000 | 72,954 | Mar 09, 2018, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 09, 2018 | Option Exercise | $8.70 | 10,000 | 87,000 | 82,954 | Mar 09, 2018, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 09, 2018 | Sale | $32.50 | 10,000 | 325,000 | 72,954 | Mar 09, 2018, 08:34 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Feb 15, 2018 | Option Exercise | $31.75 | 1,136 | 36,068 | 72,954 | Feb 16, 2018, 07:45 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Feb 15, 2018 | Option Exercise | $31.75 | 1,509 | 47,911 | 83,597 | Feb 16, 2018, 07:44 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 15, 2018 | Option Exercise | $31.75 | 3,074 | 97,600 | 158,491 | Feb 16, 2018, 07:42 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Jan 28, 2018 | Option Exercise | $33.50 | 990 | 33,165 | 65,965 | Jan 30, 2018, 09:06 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Jan 15, 2018 | Option Exercise | $34.50 | 4,327 | 149,282 | 73,356 | Jan 17, 2018, 09:51 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Dec 29, 2017 | Option Exercise | $22.99 | 443 | 10,186 | 66,955 | Jan 03, 2018, 08:27 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Dec 29, 2017 | Option Exercise | $22.99 | 127 | 2,920 | 133,315 | Jan 03, 2018, 08:13 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Dec 26, 2017 | Option Exercise | $8.70 | 17,506 | 152,302 | 66,512 | Dec 28, 2017, 08:51 PM | |
| RVNC | Revance Therapeutics, Inc. | Joshi Abhay | Chief Operating Officer | Dec 14, 2017 | Option Exercise | $32.15 | 3,229 | 103,812 | 77,683 | Dec 18, 2017, 08:26 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Nov 22, 2017 | Sale | $24.94 | 7,600 | 189,570 | 133,188 | Nov 24, 2017, 04:06 PM | |
| RVNC | Revance Therapeutics, Inc. | Foley Mark J | Director | Nov 07, 2017 | Buy | $26.96 | 20,000 | 539,168 | 20,000 | Nov 09, 2017, 07:47 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Nov 07, 2017 | Option Exercise | $8.70 | 10,000 | 87,000 | 59,006 | Nov 09, 2017, 07:46 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Nov 07, 2017 | Sale | $26.83 | 10,000 | 268,267 | 49,006 | Nov 09, 2017, 07:46 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Oct 18, 2017 | Sale | $26.16 | 7,662 | 200,405 | 140,788 | Oct 20, 2017, 08:10 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Oct 12, 2017 | Sale | $26.67 | 11,164 | 297,760 | 49,006 | Oct 16, 2017, 08:20 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Sep 20, 2017 | Sale | $23.58 | 7,600 | 179,185 | 148,450 | Sep 22, 2017, 08:08 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Aug 23, 2017 | Option Exercise | $2.55 | 331 | 844 | 178,850 | Aug 25, 2017, 07:41 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Aug 23, 2017 | Sale | $22.76 | 22,800 | 519,031 | 156,050 | Aug 25, 2017, 07:41 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Jun 30, 2017 | Option Exercise | $18.32 | 604 | 11,064 | 60,170 | Jul 05, 2017, 09:32 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 30, 2017 | Option Exercise | $18.32 | 1,000 | 18,317 | 178,519 | Jul 05, 2017, 09:29 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Jun 12, 2017 | Option Exercise | $2.55 | 8,300 | 21,165 | 177,519 | Jun 14, 2017, 08:11 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 30, 2017 | Option Exercise | $2.55 | 5,000 | 12,750 | 169,219 | May 31, 2017, 09:38 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | May 26, 2017 | Option Exercise | $8.70 | 23,000 | 200,100 | 59,566 | May 31, 2017, 09:01 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | May 22, 2017 | Sale | $20.20 | 1,793 | 36,212 | 36,566 | May 24, 2017, 09:14 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 22, 2017 | Sale | $20.20 | 12,287 | 248,159 | 183,932 | May 24, 2017, 09:13 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | May 24, 2017 | Sale | $20.35 | 19,713 | 401,091 | 164,219 | May 24, 2017, 09:13 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Mar 16, 2017 | Option Exercise | $19.20 | 1,269 | 24,366 | 38,359 | Mar 17, 2017, 07:24 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Mar 16, 2017 | Option Exercise | $19.20 | 3,171 | 60,885 | 196,219 | Mar 17, 2017, 07:23 PM | |
| RVNC | Revance Therapeutics, Inc. | Browne L Daniel | CEO and President | Feb 22, 2017 | Sale | $20.57 | 11,037 | 227,050 | 200,659 | Feb 24, 2017, 09:04 PM | |
| RVNC | Revance Therapeutics, Inc. | SILVERNAIL LAUREN P | CFO, CBO & Secretary | Jan 28, 2017 | Option Exercise | $20.00 | 1,063 | 21,260 | 39,628 | Jan 30, 2017, 09:27 PM |
Menu